$APYX

$2.46 +$0.09 (3.8%) Close

$APYX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 42.1M shares outstanding

Who owns APYX?

By type of holder

Institutions 49.3% Insiders 5.5% Everyone else 45.2%

Concentration Top 10 holders own 40.4%

Nantahala Capital Management, LLC 7.8% · Royce & Associates LP 7.8%

Institutional ownership

49.3%

+0.6 pts vs last qtr

Institutional holders

-1 vs last qtr

Net shares bought

+250.0K

by institutions in Q2 2026

New / sold out

10 / 11

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Royce & Associates LP +662.8K
Renaissance Technologies LLC +251.9K

Biggest sellers in Q2 2026

Sei Investments Co −317.2K
Susquehanna International Group, LLP SOLD OUT −267.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Apyx Medical Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2014–FY2023

+95.0%

+7.70% a year

Each share's claim on the business

−48.7%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $29.6M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years50% 3–5 years1% 1–3 years26% Under 1 year23%

Quarterly turnover

8.7%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting APYX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
NC Nantahala Capital Management, LLC	3.3M	7.76%	−170.1K (−4.9%)	2024	0.5%
Shares held by quarter Peak holding4.0M (Q4'25) Change over 8 quarters+3.3M Share of the company7.760% Nantahala Capital Management, LLC's full portfolio →
RA Royce & Associates LP	3.3M	7.77%	+662.8K (+25.4%)	≤2021	0.1%
Shares held by quarter Peak holding3.3M (Q2'26) Change over 8 quarters+691.6K Share of the company7.770% Royce & Associates LP's full portfolio →

Nantahala Capital Management, LLC

3.3M

% of company

7.76%

Change vs last qtr

−170.1K (−4.9%)

Held since

2024

Royce & Associates LP

3.3M

% of company

7.77%

Change vs last qtr

+662.8K (+25.4%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Apyx Medical Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting APYX on Form N-PORT; together they hold 13.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$4.92M	1.1M	2.60%	0.00%	June 30, 2026
RM Royce Micro-Cap Trust, Inc. Royce Micro-Cap Trust, Inc.	$4.37M	973.3K	2.31%	0.48%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$4.92M

% of company

2.60%

% of the fund

0.00%

As of

June 30, 2026

Royce Micro-Cap Trust, Inc.

Position value

$4.37M

% of company

2.31%

% of the fund

0.48%

As of

June 30, 2026

21 more funds behind a free account

See every fund holding Apyx Medical Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
VS Vizirgianakis Stavros G. Insider	1.7M	4.15%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company4.150% Vizirgianakis Stavros G.'s insider activity →
CM Citronowicz Moshe Insider	493.5K	1.17%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.170% Citronowicz Moshe's insider activity →

Vizirgianakis Stavros G.

Insider

1.7M

% of company

4.15%

Change vs last qtr

—

Held since

—

Citronowicz Moshe

Insider

493.5K

% of company

1.17%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Apyx Medical Inc.

Comments